Skip to content

Supplier News

Eos Products hires Kang as new CMO

Eos Products hires Kang as new CMO

Eos Products, known for its iconic lip balms, shave creams, and hand & body lotions, has appointed of Soyoung Kang as chief marketing officer. In her new role, Kang is responsible for global brand strategy, communications, and innovation.

Dermira gets FDA approval for Qbrexza cloth

Dermira gets FDA approval for Qbrexza cloth

Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Novartis seeks approval to spinoff Alcon eye care biz

Novartis seeks approval to spinoff Alcon eye care biz

Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.

gel-e expands its OTC label

gel-e expands its OTC label

gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (O-T-C) use of its first flowable hemostat.

Avella to distribute Braftovi and Mektovi

Avella to distribute Braftovi and Mektovi

Avella has announced that it will distribute Braftovi (encorafenib and Mektovi (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma.

Aurobindo launches atazanavir capsules

Aurobindo launches atazanavir capsules

Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.

Upsher-Smith featuring Platinum Pass at AHS meeting

Upsher-Smith featuring Platinum Pass at AHS meeting

Upsher-Smith Laboratories (Upsher-Smith)  announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28  to  July 1,  in